Insider Shareholders with Direct Ownership of Panbela Therapeutics, Inc. (PBLA)
This section provides a comprehensive overview of the insiders with direct ownership of Panbela Therapeutics, Inc. (PBLA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Panbela Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Jeffrey E. Jacob
Director |
33,000 | 0 | 294,931 $94,377 | 1 |
Oct 04, 2022
Added 10.06%
|
Michael T. Cullen
Director |
4,316 | 0 | 216,811 $69,379 | 1 |
May 25, 2021
Added 1.95%
|
Paul W. Schaffer
Director |
7,191 | 0 | 166,671 $53,334 | 2 |
May 25, 2021
Added 2.52%
|
Donald Robert Schemel
Director |
7,191 | 0 | 96,619 $30,918 | 2 |
May 25, 2021
Added 4.28%
|
Suzanne Gagnon
Director |
3,284 | 0 | 46,284 $14,810 | 1 |
Jan 06, 2021
Added 6.63%
|
Susan Horvath
V.P. of Finance & CFO |
4,444 | 0 | 17,880 $5,721 | 1 |
Jan 30, 2023
Added 19.91%
|
Jeffrey S Mathiesen
Director |
7,191 | 0 | 10,191 $3,261 | 2 |
May 25, 2021
Added 29.75%
|
Arthur Fratamico
Director |
7,191 | 0 | 9,615 $3,076 | 2 |
May 25, 2021
Added 30.98%
|
Jennifer K. Simpson
President and CEO |
4,444 | 0 | 7,868 $2,517 | 1 |
Jan 30, 2023
Added 36.09%
|